Volume 11, Number 10—October 2005
Research
Community-associated Methicillin-resistant Staphylococcus aureus, Minnesota, 2000–2003
Jessica M. Buck*
, Kathryn Como-Sabetti*, Kathleen H. Harriman*, Richard N. Danila*, David J. Boxrud*, Anita Glennen*, and Ruth Lynfield*
, Kathryn Como-Sabetti*, Kathleen H. Harriman*, Richard N. Danila*, David J. Boxrud*, Anita Glennen*, and Ruth Lynfield*Table 1
Community-associated methicillin-resistant Staphylococcus aureus invasive infection sites and skin and soft tissue infection clinical manifestations
| Site or manifestation | No. (%) |
|---|---|
| Invasive infection site (n = 65) | |
| Bloodstream infection | |
| Without focus | 25 (38) |
| With skin focus | 6 (9) |
| With respiratory focus | 2 (3) |
| Pleural fluid | 3 (5) |
| Peritoneal fluid | 2 (3) |
| Joint/bone | 21 (32) |
| Other* | 6 (9) |
| Skin and soft tissue clinical manifestation (n = 511†) | |
| Abscess | 251 (49) |
| Cellulitis | 171 (33) |
| Folliculitis | 28 (5) |
| Wound infection | 27 (5) |
| Impetigo | 11 (2) |
| Other‡ | 62 (12) |
*Other invasive isolate sources included brain tissue (1), lymph nodes (2), pancreatic aspirate (1), kidney abscess aspirate (1), and internal tissue (1).
†A total of 411 skin and soft tissue infection patients had clinical manifestations reported. Results include multiple clinical manifestations per patient.
‡Other skin clinical manifestations included psoriasis, mastitis, cystic acne, furuncles, carbuncles, insect/spider bites, and eczema.
